Tumor grade of clear cell renal cell carcinoma assessed by contrast-enhanced computed tomography by Kousei Ishigami et al.
a SpringerOpen Journal
Ishigami et al. SpringerPlus 2014, 3:694
http://www.springerplus.com/content/3/1/694RESEARCH Open AccessTumor grade of clear cell renal cell carcinoma
assessed by contrast-enhanced computed
tomography
Kousei Ishigami1*, Leandro V Leite1, Marius G Pakalniskis1, Daniel K Lee2, Danniele G Holanda3 and David M Kuehn1Abstract
The purpose of this study was to clarify the association between CT findings and Fuhrman grade of clear cell renal cell
carcinoma (ccRCC). The study group consisted of 214 surgically proven ccRCC in 214 patients. Contrast-enhanced CT
studies were retrospectively assessed for tumor size, cystic versus solid, calcification, heterogeneity of lesions, percentage
of non-enhancing (necrotic) areas, and growth pattern. CT findings and Fuhrman grade were compared. Nineteen of 22
(86.4%) cystic ccRCC were low grade (Fuhrman grades 1-2). There was no significant correlation between tumor size and
grade in cystic ccRCC (P = 0.43). In predominantly solid ccRCC, there was significant correlation between tumor size and
grade (P < 0.0001). Thirty-eight of 43 (88.4%) infiltrative ccRCC were high grade (Fuhrman grades 3-4). Logistic regression
showed tumor size and infiltrative growth were significantly associated with grades 3-4 (P = 0.00083 and P = 0.0059).
Cystic ccRCC tends to be low grade. Infiltrative growth and larger tumor size may increase the likelihood of high
grade ccRCC.
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Growth patternIntroduction
Clear cell renal cell carcinoma (ccRCC) is the most
common subtype of RCC, accounting for approximately
70 - 80% of RCC (Leibovich et al. 2010; Teloken et al.
2009; Kim et al. 2002). It has a poorer prognosis than
other subtypes of RCC, such as papillary and chromo-
phobe RCC (Leibovich et al. 2010; Teloken et al. 2009),
and its biological aggressiveness significantly affects
prognosis.
The system most widely employed to classify RCC is the
Fuhrman grading system, which uses the characteristics of
the nuclei and nucleoli of tumor cells as its basis for grad-
ing (Fuhrman et al. 1982; Novara et al. 2007; Ficarra et al.
2005). Fuhrman grade 1 is the least aggressive type, with
grade 4 being the most aggressive (Fuhrman et al. 1982).
Grades 1–2 and 3–4 are classified as low and high grades,
respectively (Novara et al. 2007; Ficarra et al. 2005). Higher
grade tumors have an elevated risk of postoperative* Correspondence: Ishigamikousei@aol.com
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in any medium, provided the original work is precurrence (Novara et al. 2007); thus, postoperative sur-
veillance for these patients should be more rigorous.
The Fuhrman grade is one of the most effective para-
meters used in predicting the biological aggressiveness
and metastatic potential of ccRCC and papillary RCC
(Novara et al. 2007; Sukov et al. 2012; Nishikimi et al.
2011), although it lacks prognostic significance for chro-
mophobe RCC (Cheville et al. 2012).
Imaging assessment of tumor grades in RCC may aid in
clinical management decisions. For example, less invasive
procedures (e.g., nephron-sparing surgery and radiofre-
quency ablation) or close observation may be considered
for low grade RCC.
There have been few previous reports citing use of
magnetic resonance imaging (MRI) to compare Fuhrman
grade with imaging characteristics, and the number of
cases reported was relatively small (Vargas et al. 2013;
Goyal et al. 2012; Rosenkrantz et al. 2010). Computed
tomography (CT) is most often used for preoperative
evaluation of RCC, and image quality is generally similar
across institutions. Therefore, CT may be more applicable
in evaluating significant numbers of cases.an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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This retrospective study was approved by the Institutional
Review Board in the University of Iowa Hospitals and
Clinics and informed consent was waived.
A computerized search of the pathology and radiology
database at our institution found 235 cases of clear cell
renal cell carcinoma (ccRCC) that had undergone com-
puted tomography (CT) between November 2007 and
November 2012. Five cases that had only unenhanced
CT were excluded, as well nine biopsy proven cases (as
tumor grade from the biopsy specimen may not be iden-
tical to the actual tumor grade (Novara et al. 2007). Six
cases of mixed clear cell and papillary (n = 5) and chro-
mophobe (n = 1) RCC were also excluded because the
biological aggressiveness is different. Additionally, one
multiple ccRCC case was excluded because the tumor
grades of each nodule were difficult to correlate. In cases
of multifocal ccRCC, the largest lesion was evaluated to
avoid the bias when performing the statistical analysis.
The study group therefore consisted of 214 patients with
214 ccRCC that had undergone surgical resection and
preoperative contrast-enhanced CT studies. One case
was multilocular cystic RCC, a variant of ccRCC with an
excellent prognosis (Suzigan et al. 2006; You et al. 2011;
Hindman et al. 2012).
The patient group consisted of 138 males and 76
females. The ages ranged from 25 to 86 years old (mean ±
standard deviation [SD]: 58 ± 13 years old). There were
102 ccRCCs found in the right kidney and 112 in the left
kidney. Of these, 9 were classified as Fuhrman grade 1,
107 grade 2, 72 grade 3, and 26 grade 4 ccRCC. Fuhrman
grade was determined by the attending pathologists who
were blind to radiology findings. Because Fuhrman grades
were obtained from pathology reports, pathologists did
not re-evaluate the pathology specimens.
Imaging analysis
Contrast-enhanced CT protocols and CT units were
somewhat variable, as the study group recruited spanned
a five-year period. All examinations were performed with
multi-detector row CT equipped with 4, 16, or 64 detec-
tor rows. Non-ionic intravenous contrast (300, 320, 350,
or 370 mgI/mL) was administered at 94 ml to 152 ml.
The venous phase was obtained in 209 cases, including
94 late corticomedullary differentiation nephrographic
and 115 homogeneous nephrographic phases. In the five
cases where venous phase was not available, the early
corticomedullary differentiation nephrographic (arterial)
phase was available for review. The early corticomedullarydifferentiation nephrographic and delayed (excretory) pha-
ses were performed in 45 and 171 cases, respectively.
Section thickness was 2, 3, or 5 mm. In addition, coronal
and sagittal multiplanar reformatted (MPR) images were
available for review in 190 cases.
CT studies were retrospectively reviewed by an expe-
rienced body imaging radiologist who had 18 years of
experience. The reviewer knew the diagnosis of RCC but
was blinded to the Fuhrman grade. MPR images were
utilized if they were available. The reviewer measured
the maximum diameter of the tumor size (if MPR images
were available, they were utilized for the measurements).
The measurements were performed twice on separate
days and average data was recorded. Presence or absence
of calcification was also recorded.
Tumors were classified as either cystic or predominantly
solid. Cystic ccRCC was diagnosed if the tumor consisted
of more than 75% of unilocular or multilocular fluid-filled
non-enhancing component (Beddy et al. 2014; Koga et al.
2000; Han et al. 2004; Hartman et al. 1986) with a re-
cognizable outer wall and/or internal septations. When an
irregular solid component was circumferential, it was con-
sidered as ccRCC with central necrosis rather than cystic
ccRCC. Cystic ccRCCs were classified using the Bosniak
classification system (Israel & Bosniak 2005). Predomin-
antly solid ccRCCs were classified into three types based
on tumor margins: (1) well-circumscribed (expansive tumor
growth with well-circumscribed and round tumor margin);
(2) lobulated (lobulated tumor contour with well-defined
tumor margin); or (3) infiltrative (indistinct border between
the tumor and normal kidney).
Tumor enhancement for predominantly solid ccRCC
was further classified as either homogenous and heteroge-
neous. In addition, the proportion of the non-enhancing
(necrotic) area within the predominantly solid ccRCC was
classified as 0 - 20%, 20 - 40%, 40 - 60%, and 60% or more.
Statistical analysis
Fuhrman grades and imaging findings were compared
using the Fisher’s exact test and the Kruskal-Wallis exact
test. Tumor size was compared using the Student-t or
Welch t-test. The correlation between the tumor grade
and size was assessed by Spearman’s rank correlation. In
addition, the receiver operating characteristic (ROC) curve
was fit to determine the cut-off value for tumor size in the
diagnosis of Fuhrman grades. Finally, logistic regression
was utilized to find significant variables that would suggest
Fuhrman grades 3–4 and grade 4 RCC, respectively.
All statistical analyses were performed using EZR (Sai-
tama Medical Centre, Jichi Medical University; http://
www.jichi.ac.jp/saitama-sct/SaitamaHP.files/statmedEN.
html; Kanda, 2012), a graphical user interface for R (The
R Foundation for Statistical Computing, Vienna, Austria,
version 2.13.0). More precisely, EZR is a modified version
Table 1 Fuhrman grades of clear cell renal cell carcinoma (ccRCC) in each morphology
Fuhrman grade Total
1 2 3 4
Cystic* 3 (13.6%) 16 (72.7%) 3 (13.6%) 0 (0%) 22
Well-circumscribed 6 (5.0%) 72 (60.5%) 38 (31.9%) 3 (2.5%) 119
Lobulated† 0 (0%) 14 (46.7%) 12 (40.0%) 4 (13.3%) 30
Infiltrative‡ 0 (0%) 5 (11.6%) 19 (44.2%) 19 (44.2%) 43
Note. *Cystic ccRCC has significantly lower grades than well-circumscribed ccRCC (P =0.025). †Lobulated ccRCC is higher grade than well-circumscribed ccRCC
(P =0.018). ‡Infiltrative ccRCC is higher grade than lobulated ccRCC (P =0.00029).
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tical functions frequently used in biostatistics (Kanda
2013). All P-values were two sided, and P-values of less
than 0.05 were considered statistically significant.
Results
Of the 214 surgically resected clear cell renal cell carcin-
oma (ccRCC), 22 were cystic and 192 were predomin-
antly solid. In predominantly solid ccRCC, 119 were
well-circumscribed, 30 were lobulated, and 43 were
infiltrative (Table 1). Of the 22 cystic ccRCC, 12 were
Bosniak III, and 10 were Bosniak IV. The tumor sizes in
cystic, well-circumscribed, lobulated and infiltrative
ccRCC are shown in Table 2. There was no significant
difference in size between cystic and well-circumscribed
ccRCC. Infiltrative ccRCC was the largest followed by
lobulated and well-circumscribed ccRCCs.
Tumor morphology and Fuhrman grade are shown in
Table 1. Nineteen of 22 (86.4%) cystic ccRCC were low
grade (Fuhrman grades 1 or 2) (Figure 1) (Tables 1 and 2).
All of the three cystic ccRCC with grade 3 were Bosniak
IV (Figure 2). There was a significant difference in
tumor grade between cystic ccRCC and well-circum-
scribed ccRCC (P = 0.025). Thirty-eight of 43 (88.4%) infil-
trative ccRCC were high grade (Fuhrman grades 3 or 4)
(Figure 3). There were significant differences in tumor
grades between well-circumscribed (Figure 4) and lobu-
lated ccRCC (Figure 5) (P = 0.018), and between lobulated
and infiltrative RCC (P = 0.00029).
In cystic ccRCC, there was no significant correlation
between tumor size and Fuhrman grade. Spearman’sTable 2 Tumor size of ccRCC in each morphology
Range (cm) Mean ± standard deviation
Cystic 1.3 - 7.7 4.1 ± 1.5
Well-circumscribed 1.1 - 13.4 3.9 ± 2.1
Lobulated† 4.2 - 14.5 8.0 ± 2.6
Infiltrative‡ 3.8 – 17.2 10.7 ± 3.0
There is no significant difference in size between cystic and well-circumscribed
ccRCC (P = 0.75). †Lobulated ccRCC was significantly larger than well-circumscribed
ccRCC (P <0.0001). ‡Infiltrative ccRCC was significantly larger than lobulated RCC
(P = 0.00023).rank correlation Rho was −0.179 (P = 0.43, Figure 6a).
By contrast, in predominantly solid ccRCC, there was sig-
nificant correlation between tumor size and Fuhrman grade.
Spearman’s rank correlation Rho was 0.51 (P <0.0001,
Figure 6b).
Receiver operating characteristic (ROC) curves showed
the cut-off value of 5.0 cm in the diagnosis of Fuhrman
grades 3-4 ccRCC. The sensitivity, specificity, and the
area under the ROC curve were 69.4%, 69.8%, and 0.740,
respectively.
Other imaging findings including calcification, heterogen-
eity of the lesions, and the percentage of non-enhancing
(necrotic) area within the predominantly solid ccRCC are
summarized in Table 3. The univariate analysis of imaging
findings and the Fuhrman grades are shown in Table 4.
Univariate analysis showed that calcification and ≥60% of
non-enhancing area were significantly more common in
high grade ccRCC than in low grade ccRCC. There was no
significant difference between heterogeneous and homo-
geneous ccRCC. In addition, the mean size of ccRCCFigure 1 A 43-year-old male with Fuhrman grade 2 cystic clear
cell renal cell carcinoma (ccRCC). Contrast-enhanced transverse CT
image demonstrates an exophytic multilocular cystic mass in the
inferior pole of the right kidney (arrow). Although multiple relatively
thick enhancing septa are seen, no solid component is identified.
This cystic ccRCC was categorized as Bosniak III.
Figure 2 A 58-year-old male with Fuhrman grade 3 cystic ccRCC. a: Contrast-enhanced transverse image demonstrates a complex cystic
mass in the left kidney (asterisk). An enhancing solid component with cystic change (small arrow) is noted on the left border of the cyst wall
(large arrow). b: The section obtained through the inferior portion of the lesion below Figure 2a shows relatively larger solid enhancing components
(large arrows) with cystic change (small arrow). This cystic ccRCC was categorized as Bosniak IV.
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calcification (10.0 ± 3.9 cm vs. 5.1 ± 3.0 cm, P <0.0001)
(Figure 3).
Logistic regression analysis showed the tumor size
and infiltrative growth were significant variables to
correlate with Fuhrman grades 3–4 ccRCC (P = 0.00083
and P = 0.0059, respectively, Table 5). Calcification, lobu-
lated contour, and ≥60% non-enhancing area were not
significant variables for Fuhrman grades 3–4.
Discussion
Clear cell renal cell carcinoma (ccRCC) is the most com-
mon subtype of RCC, followed by papillary and chro-
mophobe RCCs. Characteristics of ccRCC are possible
to differentiate from papillary and chromophobe RCCs
on diagnostic imaging (Kim et al. 2002), although it is not
100% accurate. Because papillary RCC is generally moreFigure 3 A 43-year-old male with Fuhrman grade 4 ccRCC showing in
heterogenous mass in the left kidney. The border between the tumor and
(small arrows). A large arrow and asterisk show tumor thrombus in the left ren
contrast-enhanced CT below the level of Figure 3A demonstrates the inferi
calcifications (arrows).indolent than ccRCC (Leibovich et al. 2010; Teloken et al.
2009), and Fuhrman grade lacks prognostic significance
for chromophobe RCC (Cheville et al. 2012), papillary and
chromophobe RCCs were not considered in this study.
Oncocytoma, a less common benign renal tumor, was
beyond the scope of this study because it can be difficult
to prospectively differentiate it from ccRCC on diagnos-
tic imaging. For these reasons, we focused solely on the
imaging findings of ccRCC and their relationship to
Fuhrman grade.
In our study, cystic ccRCC was more likely (88.5%) to
be low grade (Fuhrman grades 1–2), and no correlation
was found between the size of cystic ccRCC and Fuhrman
grade (Figure 6a). These results were in keeping with
previous studies that showed cystic RCC to have a bet-
ter prognosis than solid RCC (Koga et al. 2000; Han
et al. 2004) and can be explained by the fact that fewerfiltrative growth. a: Transverse contrast-enhanced CT shows a large
normal kidney is ill-defined, representing infiltrative tumor growth
al vein and left paraaortic lymphadenopathy, respectively. b: Transverse
or portion of the tumor to be necrotic with punctate and curve linear
Figure 4 A 45-year-old male with Fuhrman grade 3 ccRCC showing
well-circumscribed tumor margin. Contrast-enhanced transverse
CT image demonstrate a predominantly solid and heterogeneously
enhancing mass (arrow) in the mid portion of the left kidney. The tumor
shows a well-circumscribed clear margin to the normal renal parenchyma.
Figure 5 A 74-year-old male with Fuhrman grade 2 ccRCC
showing lobulated tumor margin. a: Contrast-enhanced transverse
CT image shows a heterogeneously enhancing lobulated mass in the
right kidney (arrow). b: Coronal reformatted image shows lobulated
tumor contour and well-defined tumor margin to the normal renal
parenchyma (small arrows). Note calcification in the tumor (large arrow).
Figure 6 Relationship between tumor size and Fuhrman grade
in cystic ccRCC (a) and predominantly solid ccRCC (b). a: The
X-axis is tumor size (cm), and the Y-axis is Fuhrman grade (1–4). The
figure shows scatter graph and the fitted line. In cystic ccRCC, there
is no significant correlation between tumor size and Fuhrman grade.
Spearman’s rank correlation Rho was −0.179 (P =0.43). b: Scatter
graph and the fitted line of predominantly solid ccRCC. There is
significant correlation between tumor size and Fuhrman grade.
Spearman’s rank correlation Rho was 0.51 (P <0.0001).
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inantly solid RCC. Our results suggest that less invasive
procedures such as nephron-sparing surgery or close
observation may be considered for cystic RCC.
Our study did include a small percentage of high grade
(Fuhrman grades 3–4) cystic ccRCC, although it was not
statistically significant by multivariate analysis. RCC with
cystic necrosis has the worst prognosis among the cystic
RCCs (Han et al. 2004; Hartman et al. 1986), and one
previous study showed the presence of tumor necrosis
correlated with aggressive histology (Beddy et al. 2014).
Distinguishing cystic ccRCC from ccRCC with extensive
central necrosis can be a problematic in some cases,
although we did not evaluate interobserver variability on
this study. When ccRCC is equivocal for solid or cystic
type, it is recommended that the type be considered pre-
dominantly solid to avoid underestimation.
The increased likelihood of high grade tumors in
infiltrative ccRCC (88.4%) may reflect biological tumor
Table 5 Multivariate (logistic regression) analysis in the
diagnosis of Fuhrman grades 3–4 ccRCC
Odds ratio 95% CI P-value
Size* 1.2 1.1 – 1.4 0.00083
Infiltrative† 4.9 1.6 – 15.4 0.0059
Calcification 0.9 0.3 – 2.5 0.78
Lobulated 4.9 0.9 – 27.7 0.069
Non-enhancing area ≥60% 1.7 0.7 – 3.9 0.20
Note. CI = confidence interval. The data were analyzed in total 214 ccRCC cases.
*†Tumor size and infiltrative growth are significantly associated with grades
3–4 RCC.
Table 3 Imaging findings of ccRCC
Fuhrman grade Total
1 2 3 4
Homogeneous 1 7 8 0 16/192 (8.3%)
Heterogeneous 5 84 61 26 176 (91.6%)
Calcification 0 10 13 11 34/214 (15.9%)
Non-enhancing area < 20% 3 30 20 7 60/192 (30.9%)
≥ 20%, <40% 1 25 18 9 53/192 (27.3%)
≥ 40%, <60% 1 22 12 2 37/192 (19.1%)
≥ 60% 1 14 19 8 42/192 (21.6%)
Note. The data show the number of the lesions. The data in the parentheses
show the percentage. The heterogeneity of the lesions (homogeneous or
heterogeneous) and the percentage of non-enhancing (necrotic) area were
evaluated in the predominantly solid ccRCC (n = 192). The presence or absence
of calcification was evaluated in total ccRCC cases (n = 214).
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sive histology, such as type 2 papillary RCC (Yamada et al.
2008; Rosenkrantz et al. 2013) and collecting duct RCC
(Yoon et al. 2006), commonly show an infiltrative appear-
ance on imaging. Similarly, it has been reported that a
histopathological finding of infiltrative growth was a factor
indicating poor prognosis in ccRCC (Nishikimi et al.
2011). Our results suggest that careful post-operative
surveillance may be necessary for RCC with infiltra-
tive growth on imaging findings.
The association of larger tumor size with higher grade,
stage and metastasis has been described in previous re-
ports (Umbreit et al. 2012; Zhang et al. 2012). However,
it should be recognized that there can be some overlap
in CT findings between Fuhrman grades 2 and 3 ccRCC.
Calcification and 60% or more non-enhancing area were
commonly present in large tumors, which may explain
why these findings were not significant by multivariate
analysis in our study. In addition, one previous study
showed that decreased tumor vascularity was associated
with high grade RCCs (Vargas et al. 2013). Because the
CT protocols of our study group varied somewhat, ourTable 4 Univariate analysis of imaging findings of ccRCC
and Fuhrman grades





Homo/Hetero (n = 192)
8/89 8/87 1.0
Non-enhancing area†
≥60%/<60% (n = 192)
15/82 27/68 0.036
Note. The data show the number of the lesions. The heterogeneity of the lesions
(homogeneous or heterogeneous) and the percentage of non-enhancing
(necrotic) area were evaluated in the predominantly solid ccRCC (n = 192). The
presence or absence of calcification was evaluated in total ccRCC cases (n = 214).
*Calcification is significantly more common in grades 3–4 than grades 1–2.
†Non-enhancing area 60% or more within the predominantly solid clear cell
renal cell carcinoma is significantly more common in grades 3–4 than
grades 1–2.ability to evaluate tumor enhancement may have been
limited. Further study to clarify the association between
tumor neo-vascularity in ccRCC and tumor grade may be
necessary.
The limitations of this study include 1) a retrospective
study at a single institution, 2) non-uniform CT acquisi-
tion techniques, 3) no correlation of CT findings with
histopathology results except Fuhrman grade of ccRCC,
4) a retrospective review of CT findings by a single expe-
rienced radiologist without assessment of interobserver
variability, 5) inclusion of surgically proved clear cell
RCC only and exclusion of other primary renal neo-
plasms, and 6) Fuhrman grades obtained from pathology
reports without re-review.
In summary, cystic ccRCC tended to be low grade
(Fuhrman grades 1–2), and tumor size did not correlate
with tumor grade. For predominantly solid ccRCC, infil-
trative growth and larger tumor size may increase the
likelihood of high grade ccRCC (Fuhrman grades 3–4).
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